UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Obesity and Psoriatic Arthritis: A Narrative Review

Rheumatology and therapy., 2020-09, Vol.7 (3), p.447-456

2020

Volltextzugriff (PDF)

Longitudinal analysis of the patient pathways to diagnosis of psoriatic arthritis

Arthritis research & therapy, 2021-10, Vol.23 (1), p.1-252, Article 252

2021

Volltextzugriff (PDF)

Association between depression, anxiety, chronic pain, or opioid use and tumor necrosis factor inhibitor persistence in inflammatory arthritis

Clinical rheumatology, 2022-05, Vol.41 (5), p.1323-1331

2022

Volltextzugriff (PDF)

Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries

Journal of general internal medicine : JGIM, 2019-02, Vol.34 (2), p.176-178

2019

Volltextzugriff (PDF)

Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence

Rheumatology and therapy., 2022-06, Vol.9 (3), p.803-821

2022

Volltextzugriff (PDF)

The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trial

Clinical rheumatology, 2021-09, Vol.40 (9), p.3667-3677

2021

Volltextzugriff (PDF)

Protocol for a multi-center randomized controlled trial to evaluate the benefits of exercise incentives and corticosteroid injections in osteoarthritis of the knee (MOVE-OK)

Trials, 2022-07, Vol.23 (1), p.604-604, Article 604

2022

Volltextzugriff (PDF)

Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Rheumatology and therapy., 2024-04, Vol.11 (2), p.313-329

2024

Volltextzugriff (PDF)

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis

Rheumatology and therapy., 2023-08, Vol.10 (4), p.849-860

2023

Volltextzugriff (PDF)

Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey

Dermatology and therapy, 2023-06, Vol.13 (6), p.1329-1346

2023

Volltextzugriff (PDF)

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Rheumatology and therapy., 2023-12, Vol.10 (6), p.1479-1501

2023

Volltextzugriff (PDF)

Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry

Rheumatology and therapy., 2023-02, Vol.10 (1), p.187-199

2023

Volltextzugriff (PDF)

Real-World Patient Experience on the Path to Diagnosis of Ankylosing Spondylitis

Rheumatology and therapy., 2019-06, Vol.6 (2), p.255-267

2019

Volltextzugriff (PDF)

Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States

BMC rheumatology, 2020-01, Vol.4 (1), p.2-2, Article 2

2020

Volltextzugriff (PDF)

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis

BMC rheumatology, 2020-09, Vol.4 (1), p.39-39, Article 39

2020

Volltextzugriff (PDF)

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study

BMC rheumatology, 2024-05, Vol.8 (1), p.20-20, Article 20

2024

Volltextzugriff (PDF)

The Changing Face of Clinical Trials in Psoriatic Arthritis

Current rheumatology reports, 2017-04, Vol.19 (4), p.21-21, Article 21

2017

Volltextzugriff (PDF)

Micronutrients: Essential Treatment for Inflammatory Arthritis?

Current rheumatology reports, 2020-10, Vol.22 (12), p.87-87, Article 87

2020

Volltextzugriff (PDF)

Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence

Current rheumatology reports, 2015-10, Vol.17 (10), p.64-64, Article 64

2015

Volltextzugriff (PDF)

Racial Differences in Prevalence and Treatment for Psoriatic Arthritis and Ankylosing Spondylitis by Insurance Coverage in the USA

Rheumatology and therapy., 2021-12, Vol.8 (4), p.1725-1739

2021

Volltextzugriff (PDF)

Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis

Clinical rheumatology, 2018-02, Vol.37 (2), p.467-474

2018

Volltextzugriff (PDF)

Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment

Clinical rheumatology, 2024-01, Vol.43 (1), p.241-249

2024

Volltextzugriff (PDF)

Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMAN

Current rheumatology reports, 2020-11, Vol.22 (11), p.78, Article 78

2020

Volltextzugriff (PDF)

Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials

Rheumatology and therapy., 2024-07

2024

Volltextzugriff (PDF)

Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative

Archives of Dermatological Research, 2018-11, Vol.310 (9), p.701-710

2018

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink Journals - AutoHoldings

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Obesity and Psoriatic Arthritis: A Narrative Review

Longitudinal analysis of the patient pathways to diagnosis of psoriatic arthritis

Association between depression, anxiety, chronic pain, or opioid use and tumor necrosis factor inhibitor persistence in inflammatory arthritis

Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries

Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence

The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trial

Protocol for a multi-center randomized controlled trial to evaluate the benefits of exercise incentives and corticosteroid injections in osteoarthritis of the knee (MOVE-OK)

Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Inhibition of Interleukin-17 in Patients with Oligoarticular Psoriatic Arthritis

Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey

Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry

Real-World Patient Experience on the Path to Diagnosis of Ankylosing Spondylitis

Patient perspectives on the pathway to psoriatic arthritis diagnosis: results from a web-based survey of patients in the United States

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study

The Changing Face of Clinical Trials in Psoriatic Arthritis

Micronutrients: Essential Treatment for Inflammatory Arthritis?

Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence

Racial Differences in Prevalence and Treatment for Psoriatic Arthritis and Ankylosing Spondylitis by Insurance Coverage in the USA

Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis

Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment

Aiming for Cure and Preventive Initiatives in Psoriatic Disease: Building Synergy at NPF, GRAPPA, and PPACMAN

Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials

Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative

Aktive Filter

Suchergebnisse filtern